返回 Agenda
Session 4: Part 2
Session Chair(s)
Hakan Aribas, MD
CEO and Founder
ORION Healthcare, Turkey
Session 4: Machines Era in MI
Learning Objective : At the conclusion of this session, participants should: • Understand the market headwinds and how they can impact the Material Review Function • Understand the importance of medical-contextualized modern technologies • Learn how modern technologies can transform the Material Review Function and enable it to better meet business needs
Speaker(s)
Natural language processing in medical information and communication
Vilius Fokas
Nexentria Inc., United States
CEO & Co-Founder
Innovative MI Solution to Engage with Customers During and Beyond the Pandemic
Jennifer Liang, MS, MSC
Bayer Inc., Canada
Medical Information Technology & Analytics Lead, Global Medical Information
Transforming the Material Review Function through modern technologies
Sudy Vengarai
Indegene, United States
Sales Manager